Immunovant Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:IMVT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 Apr 24	SellUS$114,531	Mark Levine	Individual	3,963	US$28.90
24 Apr 24	SellUS$94,243	Michael Geffner	Individual	3,261	US$28.90
24 Apr 24	SellUS$209,207	Jay Stout	Individual	7,239	US$28.90
17 Apr 24	SellUS$990,269	Peter Salzmann	Individual	34,079	US$29.94
17 Apr 24	SellUS$293,923	Julia Butchko	Individual	10,115	US$29.94
17 Apr 24	SellUS$285,554	Mark Levine	Individual	9,827	US$29.94
17 Apr 24	SellUS$356,049	Eva Barnett	Individual	12,253	US$29.94
17 Apr 24	SellUS$240,602	William Macias	Individual	8,280	US$29.94
09 Apr 24	SellUS$149,882	Peter Salzmann	Individual	4,807	US$31.18
09 Apr 24	SellUS$115,023	Eva Barnett	Individual	3,689	US$31.18
09 Apr 24	SellUS$32,833	Julia Butchko	Individual	1,053	US$31.18
22 Feb 24	SellUS$486,362	Peter Salzmann	Individual	13,454	US$36.15
22 Feb 24	SellUS$77,144	Mark Levine	Individual	2,134	US$36.15
22 Feb 24	SellUS$77,578	Julia Butchko	Individual	2,146	US$36.15
22 Feb 24	SellUS$80,289	William Macias	Individual	2,221	US$36.15
22 Feb 24	SellUS$105,920	Eva Barnett	Individual	2,930	US$36.15
26 Jan 24	SellUS$114,778	Mark Levine	Individual	3,027	US$38.45
26 Jan 24	SellUS$383,012	Michael Geffner	Individual	10,101	US$38.45
18 Jan 24	SellUS$17,397	William Macias	Individual	424	US$41.03
11 Jan 24	SellUS$147,023	Eva Barnett	Individual	3,515	US$42.43
05 Jan 24	SellUS$147,568	Peter Salzmann	Individual	3,824	US$38.59
05 Jan 24	SellUS$50,051	Julia Butchko	Individual	1,297	US$38.59
01 Dec 23	SellUS$490,668	Atul Pande	Individual	12,350	US$40.46
22 Nov 23	SellUS$106,598	Mark Levine	Individual	3,252	US$33.52
22 Nov 23	SellUS$107,024	Julia Butchko	Individual	3,265	US$33.52
22 Nov 23	SellUS$531,581	Peter Salzmann	Individual	16,217	US$33.52
22 Nov 23	SellUS$107,024	William Macias	Individual	3,265	US$33.52
22 Nov 23	SellUS$132,920	Eva Barnett	Individual	4,055	US$33.52
25 Oct 23	SellUS$142,349	Mark Levine	Individual	4,107	US$34.66
19 Oct 23	SellUS$19,504	William Macias	Individual	530	US$36.80
10 Oct 23	SellUS$168,244	Eva Barnett	Individual	4,557	US$36.92
05 Oct 23	SellUS$189,887	Peter Salzmann	Individual	5,239	US$36.39
05 Oct 23	SellUS$62,885	Julia Butchko	Individual	1,735	US$36.39
02 Oct 23	BuyUS$58,000,008	Roivant Sciences Ltd.	Company	1,526,316	US$38.00
30 Aug 23	SellUS$1,250,338	Peter Salzmann	Individual	56,774	US$22.48
24 Aug 23	SellUS$250,340	Julia Butchko	Individual	12,332	US$20.30
24 Aug 23	SellUS$292,016	Eva Barnett	Individual	14,385	US$20.30
24 Aug 23	SellUS$249,386	Mark Levine	Individual	12,285	US$20.30
24 Aug 23	SellUS$250,340	William Macias	Individual	12,332	US$20.30
24 Aug 23	SellUS$21	Julia Butchko	Individual	1	US$20.89
24 Aug 23	SellUS$21	Eva Barnett	Individual	1	US$20.89
24 Aug 23	SellUS$21	Mark Levine	Individual	1	US$20.89
24 Aug 23	SellUS$21	William Macias	Individual	1	US$20.89
14 Aug 23	SellUS$2,207,178	Peter Salzmann	Individual	103,058	US$22.04
07 Aug 23	SellUS$2,202,096	Peter Salzmann	Individual	101,339	US$21.73
26 Jul 23	SellUS$84,725	Mark Levine	Individual	3,917	US$21.63
19 Jul 23	SellUS$67,962	Eva Barnett	Individual	2,725	US$24.94
19 Jul 23	SellUS$10,624	William Macias	Individual	426	US$24.94
12 Jul 23	SellUS$29,003	Julia Butchko	Individual	1,470	US$19.73
12 Jul 23	SellUS$63,787	Peter Salzmann	Individual	3,233	US$19.73

Insider Trading Volume

Insider Buying: IMVT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMVT?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	523	0.000343%
Individual Insiders	1,225,699	0.805%
Institutions	71,271,647	46.8%
Public Companies	79,805,331	52.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.4%.

Top Shareholders

Top 25 shareholders own 89.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
54.9%	Roivant Sciences Ltd.	79,805,331	US$2.5b	0%	no data
5.27%	FMR LLC	7,655,938	US$235.0m	-2.79%	0.02%
4.46%	The Vanguard Group, Inc.	6,478,304	US$198.9m	11.2%	no data
3.08%	BlackRock, Inc.	4,476,800	US$137.4m	-1.19%	no data
2.51%	State Street Global Advisors, Inc.	3,641,907	US$111.8m	13.2%	no data
2.04%	Perceptive Advisors LLC	2,963,212	US$91.0m	27.3%	1.76%
1.84%	Point72 Asset Management, L.P.	2,666,883	US$81.9m	-0.35%	0.17%
1.49%	Armistice Capital LLC	2,164,000	US$66.4m	50.7%	1.8%
1.3%	Alpine Global Management, LLC	1,882,704	US$57.8m	34.6%	16.33%
1.28%	T. Rowe Price Group, Inc.	1,862,043	US$57.2m	16.2%	0.01%
1.25%	Viking Global Investors LP	1,809,172	US$55.5m	0%	0.22%
1.22%	Logos Global Management, L.P.	1,775,000	US$54.5m	47.9%	6.37%
0.91%	Geode Capital Management, LLC	1,316,827	US$40.4m	3.45%	no data
0.89%	Woodline Partners LP	1,289,504	US$39.6m	71.9%	0.38%
0.88%	Fred Alger Management, LLC	1,271,762	US$39.0m	43.7%	0.19%
0.87%	Pictet Asset Management Limited	1,265,298	US$38.8m	-3.22%	0.03%
0.79%	Rock Springs Capital Management LP	1,150,123	US$35.3m	17%	0.95%
0.69%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,003,897	US$30.8m	-10.9%	0.01%
0.67%	Capital Research and Management Company	976,237	US$30.0m	0%	no data
0.67%	Redmile Group, LLC	969,621	US$29.8m	-0.76%	1.15%
0.59%	Morgan Stanley, Investment Banking and Brokerage Investments	856,061	US$26.3m	90.2%	no data
0.57%	Tavistock Life Sciences	825,000	US$25.3m	-17.5%	1.31%
0.56%	Franklin Resources, Inc.	809,478	US$24.9m	50.2%	0.01%
0.55%	Paradigm Biocapital Advisors LP	799,054	US$24.5m	0%	0.93%
0.52%	Commodore Capital LP	750,990	US$23.1m	-24.9%	1.55%